InChI=1S/C21H16/c1-13-6-7-15-12-20-17-5-3-2-4-14(17)8-9-18(20)19-11-10-16(13)21(15)19/h2-9,12H,10-11H2,1H3 |
PPQNQXQZIWHJRB-UHFFFAOYSA-N |
Cc1ccc2cc3c(ccc4ccccc34)c3CCc1c23 |
|
aryl hydrocarbon receptor agonist
An agonist that binds to and activates aryl hydrocarbon receptors (AhRs).
carcinogenic agent
A role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
(via polycyclic arene )
|
|
endocrine disruptor
Any compound that can disrupt the functions of the endocrine (hormone) system
(via polycyclic arene )
|
|
View more via ChEBI Ontology
3-methyl-1,2-dihydrocyclopenta[ij]tetraphene
|
1,2-Dihydro-3-methylbenz(j)aceanthrylene
|
ChemIDplus
|
20-MC
|
ChemIDplus
|
20-Methylcholanthrene
|
NIST Chemistry WebBook
|
20-Methylcholanthrene
|
ChemIDplus
|
3-MC
|
ChemIDplus
|
3-MCA
|
ChemIDplus
|
3-methyl-1,2-dihydrobenzo[j]aceanthrylene
|
IUPAC
|
3-Methylcholanthrene
|
KEGG COMPOUND
|
MC
|
ChemIDplus
|
MCA
|
ChemIDplus
|
Methylcholanthrene
|
ChemIDplus
|
1913890
|
Reaxys Registry Number
|
Reaxys
|
56-49-5
|
CAS Registry Number
|
KEGG COMPOUND
|
56-49-5
|
CAS Registry Number
|
ChemIDplus
|
56-49-5
|
CAS Registry Number
|
NIST Chemistry WebBook
|
11922910
|
PubMed citation
|
Europe PMC
|
16359657
|
PubMed citation
|
Europe PMC
|
24658119
|
PubMed citation
|
Europe PMC
|
26076008
|
PubMed citation
|
Europe PMC
|
7561049
|
PubMed citation
|
Europe PMC
|
|